Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Oct 31, 2025 | (Q4)Oct 31, 2025 | (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 21.99%137.99M | 8.94%42.67M | 10.14%35.05M | 39.50%30.95M | 47.04%29.33M | 14.98%113.12M | 39.16M | 31.82M | 22.19M | 19.95M |
| Cost of revenue | 26.52%100.7M | 4.94%32.53M | 14.04%22.96M | 59.59%23.43M | 58.09%21.77M | 7.00%79.59M | 31M | 20.14M | 14.68M | 13.77M |
| Gross profit | 11.23%37.3M | 24.13%10.14M | 3.42%12.09M | 0.19%7.52M | 22.37%7.55M | 39.74%33.53M | 8.17M | 11.69M | 7.5M | 6.17M |
| Operating expense | 4.10%8.65M | -9.60%2.24M | -29.20%2.44M | 88.94%2.43M | 22.66%1.54M | 10.60%8.31M | 2.48M | 3.45M | 1.28M | 1.26M |
| Selling and administrative expenses | 11.47%8.21M | 6.41%2.08M | -28.20%2.2M | 95.11%2.4M | 36.94%1.54M | 28.52%7.37M | --1.95M | --3.06M | --1.23M | --1.13M |
| -General and administrative expense | 11.47%8.21M | 6.41%2.08M | -28.20%2.2M | 95.11%2.4M | 36.94%1.54M | 28.52%7.37M | --1.95M | --3.06M | --1.23M | --1.13M |
| Other operating expenses | -53.39%440K | -68.75%165K | -37.11%244K | -46.43%30K | -99.24%1K | -47.13%944K | --528K | --388K | --56K | --132K |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | 373.35%15.37K | ---- | ---- | ---- | ---- |
| Operating profit | 13.58%28.64M | 38.83%7.9M | 17.10%9.64M | -18.14%5.09M | 22.30%6.01M | 53.03%25.22M | 5.69M | 8.24M | 6.22M | 4.92M |
| Net non-operating interest income (expenses) | 21.11%1.07M | -63.44%151K | 85.93%251K | 59.28%266K | 140.36%399K | 168.33%881K | 413K | 135K | 167K | 166K |
| Non-operating interest income | 4.46%1.29M | -38.81%268K | 17.51%302K | 19.46%307K | 46.26%411K | 58.62%1.23M | --438K | --257K | --257K | --281K |
| Non-operating interest expense | -37.22%221K | 368.00%117K | -58.20%51K | -54.44%41K | -89.57%12K | -21.60%352K | --25K | --122K | --90K | --115K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -29.37%189.27K | |||||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | 89.19%-15.22K | ---- | ---- | ---- | ---- |
| Less:Write off | ---- | ---- | ---- | ---- | ---- | -36.83%-174.05K | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 187.04%1.17M | -83.84%53K | 397.50%199K | 334.35%569K | 404.29%353K | 484.95%409K | 328K | 40K | 131K | 70K |
| Income before tax | 16.51%30.89M | 26.00%8.1M | 20.01%10.09M | -9.07%5.93M | 31.29%6.76M | 40.11%26.51M | 6.43M | 8.41M | 6.52M | 5.15M |
| Income tax | -1.55%8.37M | 1.63%2.36M | -3.93%2.98M | -43.86%1.19M | 93.25%1.83M | 51.33%8.5M | 2.33M | 3.1M | 2.13M | 948K |
| Net income | 25.03%22.52M | 39.81%5.74M | 34.01%7.11M | 7.76%4.73M | 17.32%4.93M | 35.38%18.01M | 4.1M | 5.31M | 4.39M | 4.2M |
| Net income continuous operations | 25.03%22.52M | 39.81%5.74M | 34.01%7.11M | 7.76%4.73M | 17.32%4.93M | 35.38%18.01M | --4.1M | --5.31M | --4.39M | --4.2M |
| Noncontrolling interests | -1.17M | -647K | -377K | -149K | 0 | 0 | 0 | 0 | ||
| Net income attributable to the company | 31.55%23.69M | 55.58%6.39M | 41.11%7.49M | 11.15%4.88M | 17.32%4.93M | 35.38%18.01M | 4.1M | 5.31M | 4.39M | 4.2M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 31.55%23.69M | 55.58%6.39M | 41.11%7.49M | 11.15%4.88M | 17.32%4.93M | 35.38%18.01M | 4.1M | 5.31M | 4.39M | 4.2M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -19.29%0.0431 | -4.92%0.0116 | -31.66%0.0136 | 11.43%0.0089 | 17.77%0.009 | 120.79%0.0534 | 0.0122 | 0.0199 | 0.008 | 0.0076 |
| Diluted earnings per share | 31.80%0.0431 | 54.67%0.0116 | 40.21%0.0136 | 0 | 17.77%0.009 | 35.20%0.0327 | 0.0075 | 0.0097 | 0.008 | 0.0076 |
| Dividend per share | 0.0125 | 0 | 0 | 0 | 0.0125 | |||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.